NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Practice this question and more.

What are the preferred therapies for HBV as mentioned in the text?

TDF and TAF
Entecavir and Lamivudine
Amiodarone and Azoles
Ribavirin and Interferon alpha

The correct answer is: TDF and TAF

The preferred therapies for HBV as mentioned in the text are tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF). These two medications are considered first-line treatments for hepatitis B virus due to their high efficacy, high barrier to resistance development, and favorable safety profiles compared to some of the other options. Entecavir and lamivudine are also used in the treatment of HBV but are not considered the preferred therapies due to a higher risk of resistance development with lamivudine and a lower barrier to resistance with entecavir compared to TDF and TAF. Amiodarone and azoles are not commonly used to treat HBV; amiodarone is an antiarrhythmic medication, and azoles are antifungal medications. Ribavirin and interferon alpha are used to treat hepatitis C virus (HCV), not HBV.